These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
315 related articles for article (PubMed ID: 17477809)
1. Recent developments in renal cell cancer immunotherapy. Wysocki PJ; Zolnierek J; Szczylik C; Mackiewicz A Expert Opin Biol Ther; 2007 May; 7(5):727-37. PubMed ID: 17477809 [TBL] [Abstract][Full Text] [Related]
2. Novel immunotherapeutic strategies in development for renal cell carcinoma. Inman BA; Harrison MR; George DJ Eur Urol; 2013 May; 63(5):881-9. PubMed ID: 23084331 [TBL] [Abstract][Full Text] [Related]
3. Current immunotherapeutic strategies in renal cell carcinoma. Amato RJ Surg Oncol Clin N Am; 2007 Oct; 16(4):975-86, xi-xii. PubMed ID: 18022554 [TBL] [Abstract][Full Text] [Related]
4. Checkpoint Inhibitors for the Treatment of Renal Cell Carcinoma. Ghatalia P; Zibelman M; Geynisman DM; Plimack ER Curr Treat Options Oncol; 2017 Jan; 18(1):7. PubMed ID: 28210995 [TBL] [Abstract][Full Text] [Related]
5. Immunomodulatory Therapies for Renal Cell Carcinoma. Liu M; Wu H; Shangguan D; Jiang Y; Li X; Liu S; Zhou B; Yin T; Gong Z Protein Pept Lett; 2018; 25(6):534-547. PubMed ID: 29848257 [TBL] [Abstract][Full Text] [Related]
7. Immunotherapeutic strategies for the treatment of renal cell carcinoma: where are we now? Bedke J; Stenzl A Expert Rev Anticancer Ther; 2013 Dec; 13(12):1399-408. PubMed ID: 24215158 [TBL] [Abstract][Full Text] [Related]
8. Emerging immunotherapies for renal cell carcinoma. Escudier B Ann Oncol; 2012 Sep; 23 Suppl 8():viii35-40. PubMed ID: 22918926 [TBL] [Abstract][Full Text] [Related]
9. Immunotherapy in Metastatic Renal Cell Carcinoma: A Comprehensive Review. Raman R; Vaena D Biomed Res Int; 2015; 2015():367354. PubMed ID: 26161397 [TBL] [Abstract][Full Text] [Related]
10. Immunotherapies in Early and Advanced Renal Cell Cancer. Kasenda B; Larkin J; Gore M Prog Tumor Res; 2015; 42():1-10. PubMed ID: 26376844 [TBL] [Abstract][Full Text] [Related]
11. Checkpoint Blockade - a New Treatment Paradigm in Renal Cell Carcinoma. Grünwald V Oncol Res Treat; 2016; 39(6):353-8. PubMed ID: 27259695 [TBL] [Abstract][Full Text] [Related]
13. Current Status and Future Directions of Immunotherapy in Renal Cell Carcinoma. Considine B; Hurwitz ME Curr Oncol Rep; 2019 Mar; 21(4):34. PubMed ID: 30848378 [TBL] [Abstract][Full Text] [Related]
14. [Immune anticancer response: recent advances in the treatment of renal cell carcinoma]. Bouet F; Catros V Ann Biol Clin (Paris); 2004; 62(3):257-68. PubMed ID: 15217758 [TBL] [Abstract][Full Text] [Related]
15. New therapeutic developments in renal cell cancer. Prenen H; Gil T; Awada A Crit Rev Oncol Hematol; 2009 Jan; 69(1):56-63. PubMed ID: 18752971 [TBL] [Abstract][Full Text] [Related]
16. Immunotherapy of metastatic renal cell cancer. Fishman M; Seigne J Cancer Control; 2002; 9(4):293-304. PubMed ID: 12228755 [TBL] [Abstract][Full Text] [Related]
17. [Specific cellular immunotherapy of renal cell carcinoma. Current status and prospects]. Ringhoffer M; Gschwend JE Urologe A; 2002 May; 41(3):249-57. PubMed ID: 12132274 [TBL] [Abstract][Full Text] [Related]
18. Novel treatment strategies in clear-cell metastatic renal cell carcinoma. van Spronsen DJ; de Weijer KJ; Mulders PF; De Mulder PH Anticancer Drugs; 2005 Aug; 16(7):709-17. PubMed ID: 16027518 [TBL] [Abstract][Full Text] [Related]
19. Antigenic targets for renal cell carcinoma immunotherapy. Vieweg J; Jackson A Expert Opin Biol Ther; 2004 Nov; 4(11):1791-801. PubMed ID: 15500407 [TBL] [Abstract][Full Text] [Related]
20. The Past, Present and Future of Immunotherapy for Metastatic Renal Cell Carcinoma. Chang AJ; Zhao L; Zhu Z; Boulanger K; Xiao H; Wakefield MR; Bai Q; Fang Y Anticancer Res; 2019 Jun; 39(6):2683-2687. PubMed ID: 31177102 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]